School of Breast Oncology Offers Intensive Retreat

Published: Thursday, Dec 01, 2011
Joyce A. O'Shaughnessy

Joyce A. O'Shaughnessy, MD
Co-Director, Breast Cancer Research
Baylor Charles A. Sammons
Cancer Center
Texas Oncology/US Oncology
Dallas, TX

Joyce A. O'Shaughnessy, MD, an internationally known researcher in breast cancer, recently led the 8th Annual School of Breast Oncology, an interactive program designed to immerse oncology professionals in the latest science.

The program, offered through Physicians’ Education Resource, was scheduled for November 3-6, at the Emory Conference Center in Atlanta, Georgia.

“The School of Breast Oncology is a boot camp—a 4-day, intensive retreat to help oncologists fully understand state-of-the-art breast cancer treatment,” said O’Shaughnessy, co-director of Breast Cancer Research at the Baylor Charles A. Sammons Cancer Center in Dallas, Texas.

“The meeting provides practical presentations based on day-to-day, best standards of care in significant detail and depth,” she said. “Plus, every evening there are lengthy multihour case discussions that work through the nuances in the areas of decision making for practitioners.”

The program provided a comprehensive review of the most recent data on aspects of breast cancer biology, diagnostics, prevention, and advances in treatment.

The evidence-based curriculum examined topics such as breast carcinogenesis and the management of high-risk disease, adjuvant chemotherapy and endocrine therapy, imaging modalities and their use, the management of HER2-positive disease, treatment of metastatic disease, and survivorship.

“It’s a very intensive, hands-on meeting that ensures participants are fully up to speed in being able to diagnose, prevent, and treat breast cancer—whether you’re a medical oncologist, a surgeon, or a radiation oncologist,” O’Shaughnessy said. “For the hands-on practitioner who takes care of breast cancer patients, this is your course.”

For further information on PER conferences, visit

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Medical Crossfire®: Clinical Updates on PARP Inhibition and its Evolving Use in the Treatment of CancersMay 30, 20181.5
Publication Bottom Border
Border Publication